Course Overview

Researchers modeling tumors in cell culture need a technique that faithfully recapitulates the genomic complexity, drug resistance, and metastatic properties of cancer. To do so, they develop organoid cultures that match the characteristics of patient-derived tumor xenografts and use them for cost-effective, high-throughput drug screening efforts.

This Technique Talk will discuss the challenges in breast cancer research and treatment and how to develop new methods and resources for functional precision medicine and cancer drug development.

Learning Objectives

  • How to develop genomically-diverse breast cancer organoids
  • Organoids to screen FDA-approved drugs for cancer treatment
  • How to establish a precision medicine platform in oncology

  • Tuesday, January 18, 2022

    11:30 AM – 12:30 PM Eastern Time

    This webinar will also be available on-demand.


    Alana L. Welm, PhD
    Senior Director of Basic Science
    Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research
    Huntsman Cancer Institute
    Professor, Oncological Sciences
    University of Utah

    Sponsored by



    Enroll Now

    TS_WEBINARSIGNUP_TSU_Technique Talk: CRISPR for Genome Engineering in Drosophila December 14 2021

    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.